LakeShore Biopharma Future Growth
Future criteria checks 2/6
LakeShore Biopharma is forecast to grow revenue at 46.7% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 35.6% |
| Revenue growth rate | 46.7% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 29 Aug 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2026 | 1,449 | N/A | N/A | N/A | 1 |
| 3/31/2025 | 791 | N/A | N/A | N/A | 1 |
| 3/31/2024 | 573 | -433 | -339 | -295 | N/A |
| 12/31/2023 | 544 | -334 | N/A | N/A | N/A |
| 9/30/2023 | 561 | -309 | -283 | -221 | N/A |
| 6/30/2023 | 658 | -195 | N/A | N/A | N/A |
| 3/31/2023 | 687 | -145 | -240 | -182 | N/A |
| 12/31/2022 | 698 | -95 | N/A | N/A | N/A |
| 9/30/2022 | 633 | -72 | -219 | -104 | N/A |
| 6/30/2022 | 574 | -103 | N/A | N/A | N/A |
| 3/31/2022 | 503 | -106 | -472 | -174 | N/A |
| 3/31/2021 | 257 | -192 | -351 | -247 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if H6Z0's forecast earnings growth is above the savings rate (0.8%).
Earnings vs Market: Insufficient data to determine if H6Z0's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if H6Z0's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: H6Z0's revenue (46.7% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: H6Z0's revenue (46.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if H6Z0's Return on Equity is forecast to be high in 3 years time